Peter Muhleisen

473 total citations
13 papers, 363 citations indexed

About

Peter Muhleisen is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Emergency Medicine. According to data from OpenAlex, Peter Muhleisen has authored 13 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 6 papers in Epidemiology and 3 papers in Emergency Medicine. Recurrent topics in Peter Muhleisen's work include Opioid Use Disorder Treatment (8 papers), Substance Abuse Treatment and Outcomes (5 papers) and Poisoning and overdose treatments (3 papers). Peter Muhleisen is often cited by papers focused on Opioid Use Disorder Treatment (8 papers), Substance Abuse Treatment and Outcomes (5 papers) and Poisoning and overdose treatments (3 papers). Peter Muhleisen collaborates with scholars based in Australia and United States. Peter Muhleisen's co-authors include Nicholas Lintzeris, Adrian Dunlop, Gonzalo Rivas, David J. Allsop, Mark Montebello, Jessica Booth, Jan Copeland, Iain S. McGregor, Melissa M. Norberg and Craig Sadler and has published in prestigious journals such as JAMA Psychiatry, Drug and Alcohol Dependence and Drug and Alcohol Review.

In The Last Decade

Peter Muhleisen

13 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Muhleisen Australia 8 196 160 115 76 47 13 363
Ruben Olmedo United States 9 242 1.2× 93 0.6× 71 0.6× 104 1.4× 30 0.6× 12 404
Maxine L. Stitzer United States 9 146 0.7× 214 1.3× 189 1.6× 125 1.6× 63 1.3× 10 484
Karen Rubinstein United States 4 118 0.6× 271 1.7× 147 1.3× 86 1.1× 65 1.4× 5 536
João P. De Aquino United States 10 141 0.7× 132 0.8× 63 0.5× 58 0.8× 44 0.9× 43 341
Y. Riemer Austria 10 72 0.4× 197 1.2× 199 1.7× 88 1.2× 56 1.2× 20 418
William S. John United States 13 121 0.6× 185 1.2× 186 1.6× 223 2.9× 50 1.1× 25 565
Denis Antoine United States 12 98 0.5× 210 1.3× 138 1.2× 45 0.6× 44 0.9× 33 415
John G. Gardin United States 6 79 0.4× 139 0.9× 166 1.4× 43 0.6× 29 0.6× 7 348
T. Y. Slavina Russia 8 147 0.8× 127 0.8× 149 1.3× 211 2.8× 40 0.9× 9 519
Evaristo Akerele United States 9 132 0.7× 77 0.5× 86 0.7× 78 1.0× 44 0.9× 15 306

Countries citing papers authored by Peter Muhleisen

Since Specialization
Citations

This map shows the geographic impact of Peter Muhleisen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Muhleisen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Muhleisen more than expected).

Fields of papers citing papers by Peter Muhleisen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Muhleisen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Muhleisen. The network helps show where Peter Muhleisen may publish in the future.

Co-authorship network of co-authors of Peter Muhleisen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Muhleisen. A scholar is included among the top collaborators of Peter Muhleisen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Muhleisen. Peter Muhleisen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Nielsen, Suzanne, Raimondo Bruno, Bridin Murnion, et al.. (2015). Treating codeine dependence with buprenorphine: Dose requirements and induction outcomes from a retrospective case series in New South Wales, Australia. Drug and Alcohol Review. 35(1). 70–75. 9 indexed citations
2.
Ryan, John, et al.. (2015). Chronic unfairness: equal treatment for addiction medicines?. 1 indexed citations
3.
Nielsen, Suzanne, Bridin Murnion, Adrian Dunlop, et al.. (2014). Comparing treatment‐seeking codeine users and strong opioid users: Findings from a novel case series. Drug and Alcohol Review. 34(3). 304–311. 26 indexed citations
4.
Allsop, David J., Jan Copeland, Nicholas Lintzeris, et al.. (2014). Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal. JAMA Psychiatry. 71(3). 281–281. 189 indexed citations
5.
Lintzeris, Nicholas, Suet Yi Leung, Adrian Dunlop, et al.. (2013). A randomised controlled trial of sublingual buprenorphine–naloxone film versus tablets in the management of opioid dependence. Drug and Alcohol Dependence. 131(1-2). 119–126. 36 indexed citations
6.
Muhleisen, Peter, Suzanne Nielsen, James Spence, & Nicholas Lintzeris. (2010). Crushing Sublingual Buprenorphinenaloxone Tablets: Impact Upon Dissolution Time for Supervised Dispensing. 29(2). 158–162. 4 indexed citations
7.
Nielsen, Suzanne, Paul Dietze, Adrian Dunlop, et al.. (2007). Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified. Drug and Alcohol Review. 26(2). 143–151. 25 indexed citations
8.
Muhleisen, Peter, Mary Panjari, & Nicole Lee. (2003). Buprenorphine dispensing in a cohort of community pharmacies in Victoria. 22(3). 229–234. 6 indexed citations
9.
Clark, Nicolas, Nicholas Lintzeris, & Peter Muhleisen. (2002). Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose.. PubMed. 176(4). 166–7. 22 indexed citations
10.
Lintzeris, Nicholas, Alison Ritter, Adrian Dunlop, & Peter Muhleisen. (2002). . Substance Abuse. 23(4). 245–254. 2 indexed citations
11.
Lintzeris, Nicholas, Alison Ritter, Adrian Dunlop, & Peter Muhleisen. (2002). Training Primary Health Care Professionals to Prvide Buprenorphine and LAAM Treatment. Substance Abuse. 23(4). 245–254. 18 indexed citations
12.
Kutin, Jozica, et al.. (2000). Pharmacists' provision of methadone to intoxicated clients in community pharmacies, Victoria, Australia. Drug and Alcohol Review. 19(3). 299–308. 2 indexed citations
13.
Ezard, Nadine, et al.. (1999). An evaluation of community methadone services in Victoria, Australia: results of a client survey. Drug and Alcohol Review. 18(4). 417–423. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruben Olmedo Breakdown of academic impact, for papers by Maxine L. Stitzer Breakdown of academic impact, for papers by Karen Rubinstein Breakdown of academic impact, for papers by João P. De Aquino Breakdown of academic impact, for papers by Y. Riemer Breakdown of academic impact, for papers by William S. John Breakdown of academic impact, for papers by Denis Antoine Breakdown of academic impact, for papers by John G. Gardin Breakdown of academic impact, for papers by T. Y. Slavina Breakdown of academic impact, for papers by Evaristo Akerele
Rankless by CCL
2026